Products & Alliances
PrEP Biopharm Ltd
hVIVO Innovation Areas
Challenge Study Services
Target & Biomarker Discovery
Aim Rule 26
Press and Media Contact
experimental influenza virus challenge
human monoclonal antibody
hVIVO challenge model
influenza disease model
TCN-032; anti-M2e antibody; influenza viral challenge. influenza rsearch
Scientific Papers: influenza
Scientific Paper 34 : Longitudinal study of an epitope-biased serum haemagglutination-inhibition antibody response in rabbits immunized with type A influenza virions.
Scientific Paper 57 : The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo.
Scientific Paper 56 : Associations between human leukocyte antigens and nonresponsiveness to influenza vaccine.
Scientific Paper 55 : Influenza virus carrying neuraminidase with reduced sensitivity to oseltamivir carboxylate has altered properties in vitro and is compromised for infectivity and replicative ability in vivo.
Scientific Paper 88 : Gene expression signatures diagnose influenza and other symptomatic respiratory viral infections in humans.
Scientific Paper 101 : A host transcriptional signature for presymptomatic detection of infection in humans exposed to influenza H1N1 or H3N2.
Scientific Paper 96 : Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans.
Scientific Paper 86 : Animal models in influenza vaccine testing.
Scientific Paper 80 : Low pH gel intranasal sprays inactivate influenza viruses in vitro and protect ferrets against influenza infection.
Scientific Paper 109 : A Synthetic Influenza Virus Vaccine Induces a Cellular Immune Response That Correlates with Reduction in Symptomatology and Virus Shedding in a Randomized Phase Ib Live-Virus Challenge in Humans.